5
5. Vestibular
rehabilitation
therapy
e clinician may offer vestibular rehabilitation,
either self-administered or with a clinician, in the
treatment of BPPV.
O-B
6. Medical therapy Clinicians should NOT routinely treat BPPV
with vestibular suppressant medications such as
antihistamines and/or benzodiazepines.
R-C
(against)
7a. Outcome
Assessment
Clinicians should reassess patients within one
month aer an initial period of observation or
treatment to document resolution or persistence
of symptoms.
R-C
7b. Evaluation of
treatment failure
Clinicians should evaluate, or refer to a clinician
who can evaluate, patients with persistent symptoms
for unresolved BPPV and/or underlying peripheral
vestibular or central nervous system disorders.
R-A
8. Education Clinicians should educate patients regarding the
impact of BPPV on their safety, the potential for
disease recurrence and the importance of follow-up.
R-C
Table 2. Summary of Key Action Statements (KAS) (cont'd)
Statement Action Grade
